We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8464:TWSENien Made Enterprise Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

NT$386.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nien Made trades at TWD 386, sitting below its 20‑day (395.6) and 50‑day (395.6) moving averages, signaling a short‑term bearish bias. MACD is in a bearish configuration, with the line (-6.93) under the signal (-5.74) and a negative histogram, reinforcing downside momentum. The RSI at 47 is near neutral, suggesting no immediate oversold condition. Volume has been decreasing, and 30‑day volatility is high at 43.5%, indicating a choppy trading environment. On the valuation side, the DCF‑derived fair value of ~TWD 254 is far below the current price, implying the stock is overvalued relative to intrinsic cash‑flow estimates. Yet analysts are optimistic, with a “strong_buy” consensus and a mean target of TWD 502, reflecting expectations of earnings growth (forward EPS 28.1 versus trailing 22.5) and a forward PE of 13.7.
The company generates robust cash – TWD 16.9 bn cash versus TWD 1.5 bn debt – and a free cash flow yield that comfortably supports its 4.15% dividend, which has a payout ratio of 64.5%. The dividend yield is attractive for income‑focused investors, and the payout appears sustainable given the strong operating cash flow. However, the sector—Consumer Cyclical furnishings—remains sensitive to macro‑economic cycles, adding medium‑level sector risk. Geographic exposure to the US and Europe introduces moderate currency and trade‑policy risk, while regulatory risk stays low to medium. Overall, the stock presents a mixed picture: overvaluation and bearish technicals temper the appeal of its dividend and cash strength. Investors should weigh the short‑term downside risk against the long‑term earnings visibility and dividend income.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages
  • Bearish MACD and high volatility
  • Attractive dividend may not offset downside risk

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst strong_buy consensus with mean target ~TWD 502
  • Forward earnings growth and lower forward PE
  • Strong cash balance and sustainable dividend

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Overvaluation relative to DCF fair value
  • Stable cash generation and dividend yield
  • Sector cyclicality may limit upside

Key Metrics & Analysis

Financial Health

Revenue Growth-3.50%
Profit Margin22.03%
P/E Ratio17.2
ROE23.72%
ROA14.31%
Debt/Equity5.04
P/B Ratio3.8
Op. Cash FlowNT$7.1B
Free Cash FlowNT$4.4B

Technical Analysis

TrendBearish
RSI47.0
SupportNT$360.00
ResistanceNT$424.00
MA 20NT$395.58
MA 50NT$395.63
MA 200NT$409.99
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$254.40
Target PriceNT$502.27
Upside/Downside30.12%
GradeOvervalued
TypeBlend
Dividend Yield4.15%

Risk Assessment

Beta0.71
Volatility43.53%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.